Media stories about Trupanion (NYSE:TRUP) have trended somewhat positive this week, Accern Sentiment reports. Accern identifies negative and positive news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Trupanion earned a media sentiment score of 0.17 on Accern’s scale. Accern also gave news coverage about the financial services provider an impact score of 45.8588028493191 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

These are some of the news articles that may have effected Accern Sentiment’s scoring:

Shares of Trupanion (NYSE:TRUP) traded up 0.45% during midday trading on Friday, reaching $22.50. The company had a trading volume of 76,176 shares. The stock’s market capitalization is $674.89 million. The stock’s 50 day moving average is $22.88 and its 200-day moving average is $18.14. Trupanion has a 12-month low of $13.71 and a 12-month high of $25.00.

Trupanion (NYSE:TRUP) last announced its quarterly earnings results on Tuesday, August 1st. The financial services provider reported ($0.02) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.03) by $0.01. The business had revenue of $58.30 million for the quarter, compared to analyst estimates of $57.58 million. Trupanion had a negative return on equity of 13.24% and a negative net margin of 2.71%. The company’s quarterly revenue was up 27.3% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.03) earnings per share. On average, equities research analysts predict that Trupanion will post ($0.10) earnings per share for the current fiscal year.

A number of equities research analysts have recently commented on the company. BidaskClub lowered Trupanion from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 25th. Canaccord Genuity raised their price target on Trupanion from $28.00 to $29.00 and gave the stock a “buy” rating in a research report on Wednesday, August 2nd. Cowen and Company reaffirmed an “outperform” rating and set a $28.00 price target (up previously from $19.00) on shares of Trupanion in a research report on Wednesday, August 2nd. Stifel Nicolaus reissued a “buy” rating and issued a $24.00 target price (up previously from $18.00) on shares of Trupanion in a research report on Wednesday, August 2nd. Finally, Royal Bank Of Canada lifted their target price on Trupanion from $19.00 to $26.00 and gave the company an “outperform” rating in a research report on Wednesday, August 2nd. Three analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Trupanion has an average rating of “Buy” and an average price target of $24.50.

COPYRIGHT VIOLATION NOTICE: “Somewhat Positive News Coverage Somewhat Unlikely to Affect Trupanion (TRUP) Stock Price” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this article on another website, it was illegally copied and republished in violation of international trademark and copyright laws. The original version of this article can be read at https://www.thecerbatgem.com/2017/08/13/somewhat-positive-news-coverage-somewhat-unlikely-to-affect-trupanion-trup-stock-price.html.

In other Trupanion news, insider Darryl Rawlings sold 3,500 shares of the stock in a transaction that occurred on Thursday, May 18th. The stock was sold at an average price of $16.90, for a total value of $59,150.00. Following the transaction, the insider now owns 1,474,005 shares in the company, valued at $24,910,684.50. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, major shareholder General Partner Ll Maveron III sold 6,083 shares of the stock in a transaction that occurred on Monday, May 15th. The stock was sold at an average price of $16.89, for a total value of $102,741.87. The disclosure for this sale can be found here. In the last quarter, insiders sold 46,735 shares of company stock worth $999,534.

Trupanion Company Profile

Trupanion, Inc provides medical insurance plans for cats and dogs throughout the United States, Canada and Puerto Rico. The Company operates in two business segments: subscription business and other business. The subscription business segment includes monthly subscriptions for its medical plan, which are marketed to consumers.

Insider Buying and Selling by Quarter for Trupanion (NYSE:TRUP)

Receive News & Stock Ratings for Trupanion Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion Inc and related stocks with our FREE daily email newsletter.